Details for 2010816293
Up to date per 01.04.2026
Actions
Details for 2010816293
Granted/Registered
European Patent
25.07.2012 A
11.04.2018 B1
14.09.2009
US
242238 P
21.09.2009
US
244250 P
A61K 38/19 20060101AFI20171006BHEP
Owner
SillaJen Biotherapeutics, Inc.450 Sansome Street, Suite 650 San Francisco, CA 94111US
Representative
Representative
SCHWARZ & PARTNER PATENTANWÄLTE OGWipplingerstraße 301010 WienAT
Inventor
KIRN, Davidc/o Jennerex Inc. One Market Street Suite 2260 San Francisco, CA 94105US
BREITBACH, Carolinec/o Jennerex Inc. One Market Street Suite 2260 San Francisco, CA 94105US
Information about Fees